Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
Part of paid clinical trials in Stony Brook, New York.
- Sponsor
- Stony Brook University
- Study ID
- NCT07009691
- Status
- Recruiting
Conditions
- Chronic Fatigue Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hydrogen water which is prepared from an OTC supplement. — DIETARY_SUPPLEMENTThe intervention is hydrogen water which is prepared from an OTC supplement. It involves measurement of heart rate variability.
Study Details
The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?
Key Dates
- Start date
- Jun 9, 2025
- Status verified
- Jun 2025
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Hydrogen water standard dosageThe intervention is hydrogen water which is prepared from an OTC supplement. Hydrogen water is a strong anti-oxidant.
Primary Outcome Measure
Fatigue Severity Scale [ Time Frame: 12 months ]
Central Contacts
- Fred Friedberg, PhD15167024213
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stony Brook University | Stony Brook | New York | 11794-8101 | Fred Friedberg, PhD Fred Friedberg, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Stony Brook, NY
By research site
Related Studies
- Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue SyndromePHASE2 · Recruiting · Weill Medical College of Cornell University · New York, New York
- Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue SyndromePHASE1/PHASE2 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- tVNS in Long COVID-19Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.PHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama